Showing results (61-70 of 125) with videos related to
Sort By:
Pageof 13
Circulation|September 15, 1996
Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitusS Mäkimattila, A Virkamäki, P H Groop, et al.Journal of Breath Research|March 1, 2013
Ammonia in breath and emitted from skinF M Schmidt, O Vaittinen, M Metsälä, et al.Pharmacogenetics|December 11, 1999
N-acetyltransferase-2 polymorphism, smoking and type 1 diabetic nephropathyE Korpinen, P H Groop, A Rautio, et al.Diabetic Medicine : a Journal of the British Diabetic Association|April 11, 2012
INPPL1 is associated with the metabolic syndrome in men with Type 1 diabetes, but not with diabetic nephropathyM E Hyvönen, P Ihalmo, C Forsblom, et al.Diabetic Medicine : a Journal of the British Diabetic Association|March 17, 2001
Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathyE Korpinen, P H Groop, J A Fagerudd, et al.Nordisk Medicin|May 1, 1997
[Diabetic nephropathy--screening, follow-up and treatment. Nephropathy Study Groups of The Finnish Diabetes Organization]V Koivisto, P H Groop, N P Huttunen, et al.Kidney International|September 6, 2000
Albuminuria in nondiabetic relatives of IDDM patients with and without diabetic nephropathyJ A Fagerudd, K J Pettersson-Fernholm, M K Riska, et al.Clinical Pharmacology and Therapeutics|August 13, 2013
Metabolic phenotyping of diabetic nephropathyV-P Mäkinen, A J Kangas, P Soininen, et al.Diabetologia|July 1, 1993
Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitusL Groop, A Ekstrand, C Forsblom, et al.Diabetes Care|November 1, 1987
Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatmentL Groop, P H Groop, S Stenman, et al.Pageof 13